… event, the Company will showcase its proprietary Axiomer ® RNA-editing technology platform, announce initial pipeline … for the ADAR enzymes responsible for adenosine to inosine RNA editing in humans. In addition, his group has led in the … a virtual R&D event to showcase its proprietary Axiomer RNA-editing technology platform. ProQR will also announce …
ProQR will host a virtual Investor and Analyst Event highlighting its pipeline entitled:
“Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810”
… call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently … About Axiomer ® ProQR is pioneering a next-generation RNA editing technology called Axiomer ® , which could … ® EONs are designed to recruit an endogenously expressed RNA editing system called ADAR, which can direct the change …
Chardan’s 9th Annual Genetic Medicines Conference – October 21, 2025
Company management will participate in an RNA Editing panel at 1:00 p.m. ET and will conduct 1x1 investor meetings in conjunction with the conference.
… will highlight its proprietary Axiomer™ ADAR-mediated RNA editing platform, along with updates on its pipeline of … for ADAR enzymes responsible for adenosine to inosine RNA editing in humans. Recently, this knowledge has been …